Colon cancer drug seen as long-awaited victory

Discussion in 'Current Events' started by wdlove, Feb 26, 2004.

  1. macrumors P6

    wdlove

    Joined:
    Oct 20, 2002
    #1
    The first drug to emerge from a Harvard surgeon's 34-year crusade for a new class of cancer treatments is expected to win approval within weeks from the Food and Drug Administration, validating a field of research that now embraces more than 35 diseases ranging from Alzheimer's to psoriasis, researchers said.

    The milestone of Avastin's approval for colon cancer treatment, researchers said, could be swiftly followed by other drugs for cancer and severe eye diseases based on the principle -- blocking the growth of new blood vessels -- that Dr. Judah Folkman first proposed in 1970.

    http://www.boston.com/news/local/massachusetts/articles/2004/02/26/colon_cancer_drug_seen_as_long_awaited_victory/


    Understanding Angiogenesis

    http://press2.nci.nih.gov/sciencebehind/angiogenesis/angio04.htm
     
  2. macrumors 68000

    topicolo

    Joined:
    Jun 4, 2002
    Location:
    Ottawa, ON
    #2
    This is exciting stuff! the first anti-angiogenesis drug on the market can only blaze the trail for more novel angiogenesis drugs to come onto the market and save lives.
     
  3. macrumors G3

    Counterfit

    Joined:
    Aug 20, 2003
    Location:
    sitting on your shoulder
    #3
    Cool. Now if colonoscopies weren't so darned uncomfortable...


    *kicks colon cancer in the face*
     
  4. thread starter macrumors P6

    wdlove

    Joined:
    Oct 20, 2002
    #4
    I'm very happy for Dr. Judah Folkman, on his three decades of work on angiogenesis. Many had disbelief about his theory of how cancer grows. Now that we have Avastin approved, he has been vindicated. We can all benefit from his work and that of others.
     

Share This Page